ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients

Gu, Weiguang*; Zhuang, Wenya; Zhuang, Mengxia; He, Minhong; Li, Zhihua南方医科大学; 6
Diagnostic Pathology2023-11-3DOI: 10.1186/s13000-023-01401-0
13阅读
引用收藏
分享

摘要

BackgroundDNA damage response and repair (DDR) genes are crucial for maintaining the integrity of the genome. This study aims to explore the correlation of DDR gene mutations with TMB, clinical characteristics, and outcomes to platinum-based chemotherapy and platinum-based chemotherapy/immunotherapy in non-small cell lung cancer (NSCLC) without EGFR and ALK alterations.MethodsTumor tissue from 49 patients with stage III or IV NSCLC who were without EGFR and ALK alterations were analyzed using targeted next-generation sequencing (NGS). Among them, 13 patients received first-line platinum-based chemotherapy, 32 patients received first-line platinum-based chemotherapy/immunotherapy.ResultsIn these NSCLC patients without EGFR and ALK alterations, the frequently mutated genes included TP53, KMT2D and KRAS, the most frequently mutated DDR gene was FANCG, DDR gene mutations were detected in 20 patients. The mutation frequency of homologous recombination (HR) pathway was significantly higher in lung squamous cell carcinoma (LUSC) than that in lung adenocarcinoma (LUAD) (30.8% vs. 5.7%). Among DDR positive patients, a lower percentage exhibited metastasis. Patients with DDR gene mutations, cell-cycle checkpoint pathway mutations, and BER pathway mutations had significantly higher TMB compared to those without corresponding mutations. In the patients receiving platinum-based chemotherapy/immunotherapy, the disease control rate was significantly lower in the DDR-positive group compared with that in the DDR-negative group (55.6% vs. 100.0%). Among LUAD patients receiving platinum-based chemotherapy/immunotherapy, we observed a worse overall survival (OS) in DDR-positive group, as well as poorer progression-free survival(PFS)and OS in BER-positive and FANCG mutated group.ConclusionsDDR gene mutations are associated with tumor metastasis, TMB, and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients.

学科与关键词

关键词
DDR geneNon-small cell Lung cancerPlatinum-based chemotherapyPlatinum-based chemotherapy/immunotherapyMetastasis
相关
加载中…
  • DNA damage repair gene mutations predict the efficacy of platinum-based chemotherapy and immunotherapy plus platinum-based chemotherapy in advanced non-small cell lung cancer: a retrospective Chinese cohort study
    Xiao, Zhiwei; Sun, Lingling; Zheng, Yating; Chen, Hanrui; Zheng, Xinting; Luo, Jiamin; Gu, Chuying; Lin, Ruiting; Huang, Mengli; Bai, Yuezong; Chen, Zhe-Sheng; Kinslow, Connor J.; Loh, Jerold; Lin, Lizhu*Translational Lung Cancer Research, 2022, 11(12): 2539-U159.
  • Comprehensive analysis of DNA damage repair deficiency in 10,284 pan-cancer study
    Xiao, Yanni; Lu, Di; Lei, Mingxing; Xie, Wenzhuan; Chen, Yaoxu; Zheng, Yating; Wang, Chunli; Zhao, Jing; Zhu, Zhen; Zhao, Xiaochen; Huang, Mengli; Lin, Youen*; Li, Zhongjun*; Yang, Li*Annals of Translational Medicine, 2021, 9(22): 1661.被引 13
  • DNA damage repair gene mutations predict the efficacy of immunization combined with platinum chemotherapy in advanced non-small cell lung cancer: A retrospective cohort study
    Xiao, Zhiwe; Sun, Lingling; Zheng, Yating; Chen, Hanrui; Zheng, Xinting; Luo, Jiamin; Gu, Chuying; Lin, Ruiting; Hu, Xue; Huang, Mengli; Lin, LizhuAnnual Meeting of the American-Association-for-Cancer-Research (AACR), New Orleans, LA, 2022-04-08 To 2022-04-13.
查看全部 →

发表信息

论文状态
公开发表
期刊
Diagnostic Pathology
发表日期
2023-11-03
卷期
第 18 卷, 第 1 期
页码
119
DOI
10.1186/s13000-023-01401-0
语言
ENGLISH
成果收录
SCIE
资助标注
We would like to thank Shanghai Tongshu Biotechnology Co., Ltd. for technical support, and all participants for their kind cooperation in this study.

作者

  • G

    Gu, Weiguang (通讯) (第一作者)

    6

  • Z

    Zhuang, Wenya

    2 · southern med univ · 6

查看全部 5 位作者收起作者
  • Z

    Zhuang, Mengxia

    6 · 2 · southern med univ

  • H

    He, Minhong

    6

  • L

    Li, Zhihua

    6

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417